Incidence of Donor-Specific Antibodies in Kidney-Transplant Patients Receiving an Everolimus-Based, Calcineurin Inhibitor-Free Immunosuppressive Regimen.

被引：0
|
作者：
Kamar, N. [1 ]
Fort, M. [2 ]
Cardeau-Desangles, I. [1 ]
Congy, N. [1 ]
Esposito, L. [1 ]
Guitard, J. [1 ]
Rostaing, L. [1 ]
机构：
[1] Toulouse Univ Hosp, Dept Nephrol Dialysis & Organ Transplantat, Toulouse, France
[2] Toulouse Univ Hosp, Dept Immunol, Toulouse, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1302
引用
收藏
页码：409 / 410
页数：2
相关论文
共 45 条
  • [21] Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus
    Ferreira, Alexandra
    Felipe, Claudia
    Cristelli, Marina
    Viana, Laila
    Basso, Geovana
    Stopa, Suelen
    Mansur, Juliana
    Ivani, Mayara
    Bessa, Adrieli
    Ruppel, Priscila
    Aguiar, Wilson
    Campos, Erika
    Gerbase-DeLima, Maria
    Proenca, Henrique
    Tedesco-Silva, Helio
    Medina-Pestana, Jose
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (06) : 497 - 508
  • [22] Clinical Impact of Denovo or Recurrent Donor Specific Antibodies in the First Year Post Kidney Transplant in Patients on Early Steroid Withdrawal Immunosupression Regimen.
    Adebiyi, O.
    Taber, T.
    Goggins, W.
    Mishler, D.
    Yaqub, M.
    Sharfuddin, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 414 - 414
  • [23] Comparison of an early prednisone withdrawal followed by late calcineurin inhibitor-free immunosuppressive protocol to a conventional sirolimus-based regimen for simultaneous kidney-pancreas transplantation
    Knight, Richard J.
    Podder, Hemangshu
    Lawless, Amy
    Kerman, Ronald H.
    Katz, Stephen
    Van Buren, Charles T.
    Kahan, Barry D.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 310 - 310
  • [24] Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors
    Perbos, Emma
    Juinier, Estelle
    Guidicelli, Gwendaline
    Dromer, Claire
    Merville, Pierre
    Billes, Marc-Alain
    Taupin, Jean-Luc
    Neau-Cransac, Martine
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (09) : 1054 - 1060
  • [25] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (vol 377, pg 837, 2011)
    Budde, K.
    Becker, T.
    Arns, W.
    [J]. LANCET, 2011, 377 (9782): : 2006 - 2006
  • [26] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (vol 377, pg 837, 2011)
    Budde, K.
    Becker, T.
    Arns, W.
    [J]. LANCET, 2012, 380 (9858): : 1994 - 1994
  • [27] Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
    Beland, Marc-Antoine
    Lapointe, Isabelle
    Noel, Real
    Cote, Isabelle
    Wagner, Eric
    Riopel, Julie
    Latulippe, Eva
    Desy, Olivier
    Beland, Stephanie
    Magee, Ciara N.
    Houde, Isabelle
    De Serres, Sacha A.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 (05) : 502 - 509
  • [28] Clinical significance of C4d positivity of early transplant kidney biopsies from patients with donor-specific antibodies receiving desensitization protocols
    Schroppel, B.
    de Boccardo, G.
    Sehgal, V.
    Dinavahi, R.
    Murphy, B.
    Dikman, S.
    Bromberg, J. S.
    Akalin, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 356 - 356
  • [29] FOLLOW-UP DATA FROM HERAKLES STUDY AT MONTH 24: MAINTAINED SUPERIOR RENAL FUNCTION IN PATIENTS ON AN EVEROLIMUS-BASED CALCINEURIN INHIBITOR FREE REGIMEN COMPARED TO STANDARD CYCLOSPORINE/MYCOPHENOLATE AND LOW CYCLOSPORINE/EVEROLIMUS
    Lehner, F.
    Guba, M.
    Arns, W.
    Sommerer, C.
    Neumayer, H-H
    Jacobi, J.
    Weithofer, P.
    May, C.
    Baeumer, D.
    Paulus, E-M
    Witzke, O.
    Zeier, M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 28 - 28
  • [30] PREVALENCE AND INCIDENCE OF DONOR-SPECIFIC HLA ANTIBODIES IN A COHORT OF KIDNEY TRANSPLANT PATIENTS FROM A SINGLE CENTER OUTPATIENT CLINIC FROM 2010 UNTIL 2016
    Derad, Inge
    Meyer, Lisa
    Busch, Johanna
    Ziemann, Malte
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 235 - 235
12345